Skip to main content
Premium Trial:

Request an Annual Quote

Sigma Life Sciences Joins EMBL Training Program

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sigma Life Science said today that it is working with the European Molecular Biology Laboratory (EMBL) to train researchers in using its tools in certain areas, including zinc finger nuclease and RNAi technology applications.

The Sigma-Aldrich division is working with EMBL's Advanced Training Centre in Heidelberg, Germany to provide joint training courses in key areas that use Sigma Life Sciences' technologies.

The partnership will provide "joint training courses not only to meet the future challenges in modern science, but to facilitate the networking of young and established scientists, enabling the exchange of ideas to shape the future direction of research," explained Helge Bastian, VP of Marketing for Sigma-Aldrich Research Biotech, in a statement.

EMBL is a basic research institute supported with public funding from 20 European member states.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.